JAN082019_01B2203Decided 2019-01-08I-140

A post-doctoral public health researcher's EB-1A petition was dismissed because he could only demonstrate two of the…

Dismissed Useful for: avoid these mistakes
EB-1AField: sciences (public health research, infectious disease, nutrition, clinical trials)
The outcome

This appeal was not successful at this stage

The AAO dismissed the appeal because the petitioner demonstrated only two of the required three evidentiary criteria. The criterion for original contributions of major significance was not met despite evidence of research activity.

2 / 3 criteria needed Need 1 more

1 more criterion would trigger a full merits review.

In plain English

The petitioner, a post-doctoral researcher with an M.D. and Ph.D., sought EB-1A classification based on his work in nutrition, infectious disease, and clinical trials. The Nebraska Service Center denied the petition, finding only two of the ten required criteria met. On appeal, the petitioner argued his research on vitamin D/omega-3 fatty acids, a Hepatitis A outbreak, rotavirus economic burden, HIV nutritional status, and clinical trials constituted original contributions of major significance. The AAO agreed that judging and scholarly articles criteria were met, but found the evidence for original contributions insufficient because letters of support described the research as useful rather than demonstrating field-wide impact, results on omega-3 had not yet been published, and claims about Indian government implementation of rotavirus findings were unsupported. Since only two criteria were met, no final merits determination was conducted and the appeal was dismissed.

What worked & what failed

What worked: The petitioner successfully demonstrated peer review activity for two medical journals (judging criterion) and authorship of multiple peer-reviewed articles in well-regarded journals including Vaccine and Clinical Infectious Diseases (scholarly articles criterion).

What failed: The petitioner could not establish that his research had major significance in the field as a whole: (1) key omega-3 findings had not yet been published at the time of filing; (2) expert letters described work as useful or promising rather than demonstrating actual field-wide impact; (3) an unsupported claim that the Indian government implemented his rotavirus findings was not backed by record evidence; and (4) citation data alone was insufficient without additional context showing how the work influenced the field.

Takeaway: To meet the original contributions criterion, petitioners should document concrete downstream impacts — such as government policy changes, wide implementation of methods, or field-wide adoption — rather than relying on citation counts or expert letters that only describe work as useful or promising. Evidence should be in the record at the time of filing, not anticipated for future publication.

For RFE responses & petition building

Cases like this are frequently used by attorneys when responding to RFEs or building initial petitions. The evidence patterns that worked (or failed) here directly reflect what USCIS officers look for when evaluating EB-1A criteria.

Evidence that moved the needle

  • The petitioner successfully demonstrated peer review activity for two medical journals (judging criterion) and authorship of multiple peer-reviewed articles in well-regarded journals including Vaccine and Clinical Infectious Diseases (scholarly articles criterion).

Evidence that wasn't enough alone

  • The petitioner could not establish that his research had major significance in the field as a whole: (1) key omega-3 findings had not yet been published at the time of filing
  • (2) expert letters described work as useful or promising rather than demonstrating actual field-wide impact
  • (3) an unsupported claim that the Indian government implemented his rotavirus findings was not backed by record evidence
  • and (4) citation data alone was insufficient without additional context showing how the work influenced the field.
Find more EB-1A cases with similar evidence patterns →
What the evidence showed

Criterion-by-criterion breakdown

Judging the work of others

Met

Petitioner conducted peer reviews for The American Journal of Medicine and the International Journal of STD & AIDS; Acting Director found this criterion met and AAO affirmed.

Original contributions of major significance

Not met

Research on vitamin D/omega-3 fatty acids, Hepatitis A outbreak in India, rotavirus economic burden, HIV nutritional status, and clinical trials were all evaluated but none were found to have demonstrated major significance in the field as a whole. Results not yet published, GIS use not shown to have influenced the broader field, and government implementation claims were unsupported.

Authorship of scholarly articles

Met

Petitioner authored articles in The American Journal of Clinical Nutrition, Journal of Nutrition, Vaccine, Clinical Infectious Diseases, and others; Acting Director found this criterion met and AAO affirmed.

Evidence that persuaded the AAO

Peer review activities for The American Journal of Medicine and the International Journal of STD & AIDS (judging criterion)

Scholarly articles published in The American Journal of Clinical Nutrition, Journal of Nutrition, Vaccine, and Clinical Infectious Diseases (scholarly articles criterion)

Where the evidence fell short

Omega-3 fatty acid dosage recommendation research — results had not yet been shared publicly as of the time of filing, so major impact could not be established

GIS mapping and analysis in Hepatitis A outbreak investigation — not shown to have significantly influenced the broader field

Rotavirus economic burden study — although cited by other researchers, no evidence that findings were implemented by the Indian government or otherwise impacted the field at large

HIV nutritional status research — described as useful insights but no documented impact on the field

Post-marketing clinical trial for HIV therapy drug — petitioner was listed as principal investigator but did not demonstrate field-wide impact

Clinical trials for rotavirus vaccine — claim that Indian government initiated immunization program based on petitioner's findings was unsupported by record evidence

Citation rate data (InCites, Google Scholar, Microsoft Research) — citations alone insufficient to establish major significance without contextual evidence of field impact

How the case moved

Completed

I-140 filed

Post-doctoral research associate specializing in public health, nutrition, infectious disease, and clinical trials

Completed

Nebraska Service Center — Denied

Initial decision: Denied.

Completed

Appeal to the AAO

Petitioner appealed to the Administrative Appeals Office for de novo review.

2019-01-08

AAO decision — Dismissed

The AAO dismissed the appeal because the petitioner demonstrated only two of the required three evidentiary criteria. The criterion for original contributions of major significance was not met despite evidence of research activity.

If you're appealing a similar decision, I-290B must be filed within 30 days of personal service of the denial, or 33 days if mailed.

Find this useful? A coffee helps keep Case Reviewer free and ad-free.

Buy me a coffee
Authorities the office relied on
8 C.F.R. § 204.5(h)(2)8 C.F.R. § 204.5(h)(3)8 C.F.R. § 204.5(h)(3)(i)-(x)8 C.F.R. § 204.5(h)(3)(iv)8 C.F.R. § 204.5(h)(3)(v)8 C.F.R. § 204.5(h)(3)(vi)8 C.F.R. § 103.2(b)(1)
KazarianEstablishes the two-step framework: first count qualifying criteria, then conduct a final merits determination of sustained national or international acclaim if the threshold is met
VisinscaiaSupports the Kazarian two-step analysis and defines 'contributions of major significance' as work that has significantly impacted the field
RijalFurther supports the Kazarian two-step analysis
ChawatheTruth is determined by quality of evidence, not quantity; each piece examined for relevance, probative value, and credibility
SilvermanStatutory/regulatory language is not superfluous; 'major significance' must be given independent meaning
APWU v. PotterCited for the principle that regulatory terms are not superfluous